athenahealth (NASDAQ:ATHN)‘s stock had its “buy” rating reiterated by equities research analysts at Piper Jaffray Companies in a note issued to investors on Friday, February 16th. They presently have a $160.00 target price on the health services provider’s stock. Piper Jaffray Companies’ target price points to a potential upside of 9.88% from the stock’s current price.
ATHN has been the topic of a number of other research reports. Cantor Fitzgerald restated a “hold” rating and issued a $120.00 target price on shares of athenahealth in a research report on Friday, October 27th. BidaskClub downgraded athenahealth from a “hold” rating to a “sell” rating in a research report on Tuesday, January 16th. Deutsche Bank initiated coverage on athenahealth in a research report on Friday, December 8th. They issued a “hold” rating and a $145.00 target price on the stock. KeyCorp reduced their target price on athenahealth from $170.00 to $140.00 and set an “overweight” rating on the stock in a research report on Friday, October 20th. Finally, Leerink Swann reduced their target price on athenahealth from $155.00 to $125.00 and set a “market perform” rating on the stock in a research report on Monday, October 23rd. Three research analysts have rated the stock with a sell rating, seventeen have given a hold rating and seven have issued a buy rating to the company. athenahealth has a consensus rating of “Hold” and an average target price of $144.35.
Shares of athenahealth (NASDAQ ATHN) traded down $0.39 during trading on Friday, reaching $145.62. The company had a trading volume of 489,525 shares, compared to its average volume of 545,585. athenahealth has a 52-week low of $95.01 and a 52-week high of $158.66. The stock has a market capitalization of $5,840.00, a P/E ratio of 117.44, a price-to-earnings-growth ratio of 2.58 and a beta of 1.17. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.84 and a current ratio of 1.84.
athenahealth (NASDAQ:ATHN) last posted its earnings results on Thursday, February 1st. The health services provider reported $1.11 EPS for the quarter, beating the Zacks’ consensus estimate of $0.63 by $0.48. athenahealth had a return on equity of 9.21% and a net margin of 4.35%. The company had revenue of $329.20 million for the quarter, compared to the consensus estimate of $319.64 million. During the same quarter in the previous year, the business earned $0.62 earnings per share. The company’s revenue for the quarter was up 14.2% on a year-over-year basis. equities analysts predict that athenahealth will post 2.69 EPS for the current fiscal year.
In related news, CEO Jonathan Bush sold 25,000 shares of the business’s stock in a transaction on Monday, February 5th. The stock was sold at an average price of $145.00, for a total transaction of $3,625,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Brandon H. Hull sold 653 shares of the business’s stock in a transaction on Friday, February 2nd. The stock was sold at an average price of $133.00, for a total value of $86,849.00. Following the transaction, the director now directly owns 5,230 shares of the company’s stock, valued at $695,590. The disclosure for this sale can be found here. Insiders have sold a total of 108,705 shares of company stock valued at $14,891,199 over the last three months. 3.20% of the stock is currently owned by insiders.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Allianz Asset Management GmbH boosted its position in shares of athenahealth by 67.0% during the 4th quarter. Allianz Asset Management GmbH now owns 555,766 shares of the health services provider’s stock worth $73,939,000 after acquiring an additional 223,006 shares in the last quarter. Jackson Square Partners LLC boosted its position in shares of athenahealth by 55.4% during the 3rd quarter. Jackson Square Partners LLC now owns 525,738 shares of the health services provider’s stock worth $65,380,000 after acquiring an additional 187,491 shares in the last quarter. Sumitomo Mitsui Trust Holdings Inc. boosted its position in shares of athenahealth by 124.4% during the 3rd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 276,700 shares of the health services provider’s stock worth $34,410,000 after acquiring an additional 153,400 shares in the last quarter. ARK Investment Management LLC boosted its position in shares of athenahealth by 55.5% during the 4th quarter. ARK Investment Management LLC now owns 379,439 shares of the health services provider’s stock worth $50,481,000 after acquiring an additional 135,383 shares in the last quarter. Finally, Sumitomo Mitsui Asset Management Company LTD boosted its position in shares of athenahealth by 40.3% during the 4th quarter. Sumitomo Mitsui Asset Management Company LTD now owns 454,160 shares of the health services provider’s stock worth $60,421,000 after acquiring an additional 130,545 shares in the last quarter.
athenahealth Company Profile
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.